作者：
Francesca,Toffalorio [1]
;
Mariacarmela,Santarpia [2]
;
Davide,Radice [1]
;
Christopher Adrian,Jaramillo [3]
;
Gianluca,Spitaleri [4]
;
Michela,Manzotti [5]
;
Chiara,Catania [1]
;
Lars Petter,Jordheim [6]
;
Giuseppe,Pelosi [7]
;
Godefridus J,Peters [1]
;
Carmelo,Tibaldi [6]
;
Niccola,Funel [8]
;
Lorenzo,Spaggiari [9]
;
Filippo,de Braud [10]
;
Tommaso,De Pas [5]
;
Elisa,Giovannetti [11]
作者单位：
Medical Oncology Unit of Respiratory Tract and Sarcomas, New Drugs Development Division, European Institute of Oncology, Milan, Italy.
[1]
Medical Affairs, Roche Spa, Monza, Italy.
[2]
Medical Oncology Unit, Department of Human Pathology, University of Messina, Messina, Italy.
[3]
Epidemiology and Biostatistics Division, European Institute of Oncology, Milan, Italy.
[4]
Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
[5]
Thoracic Oncology Division, European Institute of Oncology, Milan, Italy.
[6]
Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy.
[7]
Centre de Recherche en Cancérologie de Lyon, INSERM 1052/CNRS UMR 5286, Lyon, France.
[8]
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
[9]
Inter-Hospital Pathology Division, Science and Technology Park, IRCCS MultiMedica, Milan, Italy.
[10]
Division of Oncology, Department of Oncology, S. Luca Hospital, Lucca, Italy.
[11]
CNR-Nano, Institute of Nanoscience and Nanotechnology, Pisa, Italy.
[12]
Cancer Pharmacology Laboratory, AIRC Start-Up Unit, University of Pisa, Pisa, Italy.
[13]
Thoracic Surgery Division, European Institute of Oncology, Milan, Italy.
[14]
DOI
10.18632/oncotarget.24505
PMID
29662657
发布时间
2022-04-08
换一批
换一批
